Phase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma
Loading...
Embargo End Date
ICR Authors
Authors
Dreyling, MH
Morschhauser, F
Bouabdallah, K
Cunningham, D
Bron, D
Linton, K
Assouline, S
Verhoef, G
Thiebtemont, C
Vitolo, U
Garcia-Vargas, J
Gorbatchevsky, I
Neves, M
Grunet, J
Hietneyer, F
Childs, BH
Zinzani, PL
Morschhauser, F
Bouabdallah, K
Cunningham, D
Bron, D
Linton, K
Assouline, S
Verhoef, G
Thiebtemont, C
Vitolo, U
Garcia-Vargas, J
Gorbatchevsky, I
Neves, M
Grunet, J
Hietneyer, F
Childs, BH
Zinzani, PL
Document Type
Journal Article
Date
2017-09
Date Accepted
Abstract
Citation
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 pp. 310 - 310
DOI
Source Title
Publisher
ISSN
2296-5270
eISSN
2296-5262
Collections
Research Team
Medicine (RMH Smith Cunningham)